Jamil Farshchi - 10 Feb 2025 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
EVP, CISO & CTO
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
10 Feb 2025
Net transactions value
$0
Form type
4
Filing time
12 Feb 2025, 16:15:07 UTC
Previous filing
27 Nov 2024
Next filing
13 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +3,707 +11% $0.000000 38,654 10 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +11,910 $0.000000 11,910 10 Feb 2025 Common Stock 11,910 $252.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F3 Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026.